HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Takaaki Arigami Selected Research

Stents

1/2021Clinical Outcomes of Fully Covered Self-expanding Metallic Stent Placement for Palliation of Incurable Esophageal Cancer With or Without Radiotherapy.
10/2019Successful conservative treatment of spontaneous intrathoracic esophageal perforation using a temporary covered esophageal stent with a check valve: a case report.
10/2016Clinical Impact of Stomach-partitioning Gastrojejunostomy with Braun Enteroenterostomy for Patients with Gastric Outlet Obstruction Caused by Unresectable Gastric Cancer.
11/2014Clinical utility of perioperative staging laparoscopy for advanced gastric cancer.
10/2013Novel fundoplication for esophagogastrostomy after proximal gastrectomy.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Takaaki Arigami Research Topics

Disease

86Neoplasms (Cancer)
03/2024 - 05/2004
78Stomach Neoplasms (Stomach Cancer)
03/2024 - 01/2007
32Neoplasm Metastasis (Metastasis)
03/2024 - 03/2006
21Lymphatic Metastasis
03/2024 - 04/2008
16Esophageal Neoplasms (Esophageal Cancer)
10/2023 - 10/2006
13Esophageal Squamous Cell Carcinoma
08/2022 - 03/2011
11Adenocarcinoma
01/2022 - 06/2012
9Pancreatic Neoplasms (Pancreatic Cancer)
07/2022 - 02/2012
6Breast Neoplasms (Breast Cancer)
01/2019 - 01/2008
6Neoplasm Micrometastasis
01/2018 - 06/2008
5Circulating Neoplastic Cells
01/2021 - 01/2017
4Pathologic Constriction (Stenosis)
10/2023 - 10/2013
4Rectal Neoplasms (Rectal Cancer)
08/2023 - 04/2018
4Colorectal Neoplasms (Colorectal Cancer)
07/2023 - 04/2018
3Anastomotic Leak
10/2023 - 12/2017
3Colonic Neoplasms (Colon Cancer)
04/2020 - 01/2015
3Sepsis (Septicemia)
10/2019 - 06/2013
3Melanoma (Melanoma, Malignant)
02/2010 - 06/2008
2Wounds and Injuries (Trauma)
11/2022 - 10/2019
2Carcinoma (Carcinomatosis)
01/2021 - 03/2012
2Residual Neoplasm
07/2020 - 07/2010
2Infections
01/2019 - 10/2015
2Disseminated Intravascular Coagulation
12/2017 - 10/2015
2Hypoalbuminemia
12/2016 - 10/2015
2Malnutrition (Nutritional Deficiencies)
10/2015 - 05/2010
2Gastrointestinal Neoplasms (Gastrointestinal Cancer)
10/2013 - 10/2006
1Adenomatous Polyposis Coli (Familial Adenomatous Polyposis)
01/2023
1Mediastinal Emphysema (Pneumomediastinum)
12/2022
1Cholangiocarcinoma
07/2022
1Microsatellite Instability
06/2022

Drug/Important Bio-Agent (IBA)

10Paclitaxel (Taxol)FDA LinkGeneric
11/2023 - 01/2007
10Messenger RNA (mRNA)IBA
04/2018 - 06/2008
8Cisplatin (Platino)FDA LinkGeneric
11/2023 - 04/2015
7Trastuzumab (Herceptin)FDA Link
03/2024 - 12/2018
6Immune Checkpoint InhibitorsIBA
07/2022 - 03/2018
6CarbohydratesIBA
07/2022 - 01/2012
6AntigensIBA
11/2021 - 01/2012
6Proteins (Proteins, Gene)FDA Link
01/2019 - 11/2008
6Radioisotopes (Radionuclides)IBA
09/2018 - 05/2004
6Colloids (Colloid)IBA
09/2013 - 05/2004
5Docetaxel (Taxotere)FDA Link
08/2022 - 06/2013
5MicroRNAs (MicroRNA)IBA
10/2021 - 08/2017
5Fibrinogen (Factor I)FDA Link
02/2017 - 10/2015
5Hematoxylin (Haematoxylon)IBA
02/2016 - 03/2006
5Eosine Yellowish-(YS) (Eosin)IBA
02/2016 - 03/2006
4human ERBB2 proteinIBA
03/2024 - 01/2020
4Bevacizumab (Avastin)FDA Link
07/2023 - 03/2020
4Fluorouracil (Carac)FDA LinkGeneric
08/2022 - 04/2015
4Oxaliplatin (Eloxatin)FDA LinkGeneric
01/2022 - 03/2019
4NivolumabIBA
04/2021 - 01/2020
4Biomarkers (Surrogate Marker)IBA
10/2020 - 02/2010
4Therapeutic UsesIBA
03/2020 - 11/2015
4Carcinoembryonic AntigenIBA
02/2018 - 08/2008
4HLA Antigens (Human Leukocyte Antigens)IBA
11/2015 - 10/2012
3RamucirumabIBA
06/2022 - 07/2020
3C-Reactive ProteinIBA
01/2021 - 10/2015
3RNA (Ribonucleic Acid)IBA
08/2020 - 11/2008
3ParaffinIBA
07/2020 - 06/2008
3Coloring Agents (Dyes)IBA
09/2017 - 05/2004
2ErbB Receptors (EGF Receptor)IBA
12/2022 - 04/2022
2CA-19-9 Antigen (CA 19-9 Antigen)IBA
07/2022 - 11/2016
2pembrolizumabIBA
06/2022 - 04/2021
2Tumor Biomarkers (Tumor Markers)IBA
10/2021 - 10/2015
2N-acetyltalosaminuronic acid (NAT)IBA
10/2021 - 01/2018
2B7-H1 AntigenIBA
04/2021 - 03/2018
2Indocyanine Green (Cardio-Green)FDA LinkGeneric
09/2018 - 06/2016
2Cadherins (E-Cadherin)IBA
09/2017 - 03/2012
2Antineoplastic Agents (Antineoplastics)IBA
12/2016 - 06/2013
2Indicators and Reagents (Reagents)IBA
10/2015 - 01/2015
2teleocalcinIBA
12/2013 - 01/2012
2TinIBA
08/2013 - 10/2007
2LigandsIBA
05/2011 - 12/2010
2RNA-Directed DNA Polymerase (Reverse Transcriptase)IBA
10/2010 - 06/2008
2HMW-MAAIBA
02/2010 - 06/2008
2Chemokine ReceptorsIBA
07/2009 - 11/2007
2Keratins (Keratin)IBA
04/2008 - 03/2008
1Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
07/2023
1Trinitrotoluene (TNT)IBA
03/2023
1Panitumumab (Vectibix)FDA Link
03/2023

Therapy/Procedure

44Drug Therapy (Chemotherapy)
03/2024 - 08/2008
30Gastrectomy
03/2024 - 10/2007
27Therapeutics
07/2023 - 04/2007
17Neoadjuvant Therapy
08/2022 - 01/2007
16Lymph Node Excision (Lymph Node Dissection)
03/2024 - 05/2004
13Chemoradiotherapy
03/2023 - 03/2011
7Esophagectomy
10/2023 - 03/2011
6Adjuvant Chemotherapy
07/2023 - 04/2017
5Stents
01/2021 - 10/2013
4Hepatectomy
03/2024 - 01/2020
4Radiotherapy
03/2023 - 07/2010
3Immunotherapy
07/2022 - 07/2020
3Minimally Invasive Surgical Procedures
05/2019 - 02/2013
3Operative Surgical Procedures
09/2017 - 03/2011
3Gastric Bypass (Roux-en-Y Gastric Bypass)
12/2016 - 11/2014
2Ileostomy
01/2023 - 11/2014
2Colectomy
11/2022 - 04/2020
2Induction Chemotherapy
02/2019 - 01/2017
2Combination Drug Therapy (Combination Chemotherapy)
07/2010 - 01/2007
1Operative Time
08/2023
1Restorative Proctocolectomy
01/2023